Xcout Intel
CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Subscribe to see CuraSen Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CuraSen Therapeutics, Inc. at a glance
CuraSen Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $5.8M in August 2024. Xcout tracks 16 named people at CuraSen Therapeutics, Inc., including Anthony P Ford (President and Chief Executive Officer).
CuraSen Therapeutics, Inc. leadership
- Anthony P FordPresident and Chief Executive Officer
- Michael P. DillonChief Technical Officer
- Gabriel Vargas, MD, PhDChief Medical Officer
- Kathleen Sereda GlaubChief Executive Officer
- Anthony Ford, PhDPresident & Chief Scientific Officer
- Peter ButeraSenior Vice President, Operations
10 more named people on record for CuraSen Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
CuraSen Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5.8M | — | |
| Venture Round | $5.8M | 1 named | |
| SEC Form D filing | $17.6M | — | |
| SEC Form D filing | $18M | — | |
| SEC Form D filing | $27.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
CuraSen Therapeutics, Inc. competitors
A few of CuraSen Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Neurawell Therapeutics is a clinical-stage research and development company that develops central nervous system (CNS) treatments. It focuses on addressing unmet medical needs for patients suffering from conditions such as depression, major depressive disorder, treatment-resistant depression, anxiety, and neurological disorders like Parkinson's disease.
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 with headquarters in Copenhagen, Denmark, and operations in Leuven. The company discovers and develops novel therapies aimed at slowing or stopping devastating neurodegenerative diseases like Alzheimer's and Parkinson's.
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Get CuraSen Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CuraSen Therapeutics, Inc. in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access